Bronkholitin

General characteristics. Structure:

Active agents: glautsina hydrobromide of 5 mg, ephedrine hydrochloride of 4 mg;

Syrup in the form of viscous liquid, from light yellow till flavovirent or light brown color, from transparent to poorly opalescent, with a specific smell of basilic oil. 5 g

Pharmacological properties:

The combined drug with antibechic and broncholitic action.
Glautsina hydrobromide suppresses the tussive center, without leading at the same time to respiratory depression, development of locks and medicinal dependence.
Ephedrine expands bronchial tubes, stimulates breath and due to vasoconstrictive action eliminates hypostasis of a mucous membrane of bronchial tubes.
Oil of a basil renders insignificant sedative, antimicrobic and spasmolytic action.

Indications to use:

As a part of complex therapy of various respiratory diseases which are followed by dry cough including:
— acute inflammatory diseases of upper respiratory tracts;
— acute and chronic bronchitis;
— tracheobronchitis;
— HOBL;
— bronchial asthma;
— pneumonia;
— bronchoectatic disease;
— whooping cough.

Route of administration and doses:

The adult appoint 3-4 on 10 ml
To children aged from 3 up to 10 years - on 5 ml 3; to children 10 years - on 10 ml 3 are aged more senior

Features of use:

At drug use Bronkholitin it is necessary to consider that 1 measured spoon or 1 glass (5 ml) contain to 0.069 g of ethanol 96% (1.7 about. %). Influence on ability to driving of motor transport and to control of mechanisms. Because of possible emergence of dizziness and vision disorders it is necessary to be careful when performing the work requiring special attention and speed of psychomotor reactions including during the driving of the car and work with mechanisms.

Side effects:

From cardiovascular system: tachycardia, premature ventricular contraction, increase in the ABP.
From TsNS: a tremor, excitement, sleeplessness, dizziness, children have a drowsiness.
From sense bodys: vision disorder.
From the alimentary system: nausea, vomiting, anorexia, lock.
From endocrine system: increase in a libido, dysmenorrhea.
From an urinary system: difficulty of an urination, an ischuria at patients with a prostate hyperplasia.
Dermatological reactions: rash, sweating strengthening.
Others: tachyphylaxis.

Interaction with other medicines:

Bronkholitin it is possible to apply along with antibiotics, febrifuges and vitamins.
The ephedrine which is a part of drug weakens action of opioid analgetics and hypnagogues.
At use of ephedrine along with cardiac glycosides, quinidine, tricyclic antidepressants the risk of development of arrhythmias increases.
At simultaneous use of ephedrine with Reserpinum and MAO inhibitors perhaps sharp increase in the ABP.
At simultaneous use of ephedrine with non-selective beta adrenoblockers reduction of broncholitic action is possible.
There are no data on medicinal interaction of a glautsin with other medicines.

Contraindications:

— arterial hypertension;
— ISCHEMIC HEART DISEASE;
— heavy organic heart diseases;
— heart failure;
— pheochromocytoma;
— thyrotoxicosis;
— sleeplessness;
— closed-angle glaucoma;
— a prostate hyperplasia with clinical manifestations;
— thyrotoxicosis;
— I trimester of pregnancy;
— period of a lactation (breastfeeding);
— children's age up to 3 years;
— hypersensitivity to drug components.
With care patients should appoint Bronkholitin with tendency to development of medicinal dependence. Because of contents as a part of ethanol it is necessary to be careful at purpose of drug at children's age, to patients with liver diseases, an alcoholism, epilepsy, brain diseases, at pregnancy.

Use of the drug BRONKHOLITIN® at pregnancy and feeding by a breast
Drug is contraindicated to use in the I trimester of pregnancy and in the period of a lactation (breastfeeding).
During other periods of pregnancy it is necessary to appoint drug with care.

Use at abnormal liver functions
With care patients should appoint Bronkholitin with liver diseases.

Overdose:

Symptoms: nausea, vomiting, appetite loss, excitement, blood circulation disturbance, tremor of extremities, dizziness, perspiration, difficulty of an urination. Treatment: gastric lavage, symptomatic therapy.

Storage conditions:

Drug should be stored in dry, protected from light, the place, unavailable to children, at a temperature not above 25 °C; not to freeze. A period of validity - 4 years

Issue conditions:

According to the recipe

Packaging:

On 125 g of drug in the bottle of dark glass or a bottle of dark polyethyleneterephthalate corked by an aluminum cap with control of the first opening or a plastic cap from polyethylene of high pressure with the breaking-off ring. On each bottle paste the label from paper for an offset printing with the corresponding marking. Everyone the bottle together with a measuring spoon or a glass and the application instruction is placed in a pack cardboard.